Skip to main content
Figure 7 | BMC Cancer

Figure 7

From: Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis

Figure 7

The presence and distribution of OGF and OGFr in human follicular thyroid cancer cells. (A) Photomicrographs of log-phase WRO 82-1 cells visualized with differential interference (DIC) or stained with antibodies to [Met5]-enkephalin (OGF) or OGFr. Immunoreactivity was associated with the cytoplasm and a speckling of stain was noted in cell nuclei; no staining was recorded with secondary antibodies only (inset). Scale bar = 10 μm. (B) WRO 82-1 cells were treated for 48 h with 10-6 M OGF or NTX, or sterile water (Co). Values represent means ± SE for cells counted from 2 wells/treatment group from three experiments. Significantly different from controls at p < 0.05 (*) or p < 0.001 (***).

Back to article page